Loading...
Pacific Edge Limited
PEB.AX•ASX
HealthcareMedical - Diagnostics & Research
A$0.10
A$0.006(6.59%)
Pacific Edge Limited (PEB.AX) Financial Performance & Statements
Review Pacific Edge Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
32.86%
↑ 32.86%
Operating Income Growth
-33.43%
↓ 33.43%
Net Income Growth
-9.53%
↓ 9.53%
Operating Cash Flow Growth
-0.68%
↓ 0.68%
Operating Margin
-190.86%
↓ 190.86%
Gross Margin
48.86%
↑ 48.86%
Net Profit Margin
-127.26%
↓ 127.26%
ROE
-57.46%
↓ 57.46%
ROIC
-101.76%
↓ 101.76%
Pacific Edge Limited (PEB.AX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Pacific Edge Limited stock.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $11.34M | $11.28M | $13.10M | $5.78M |
| Cost of Revenue | $5.96M | $5.61M | $6.14M | $2.44M |
| Gross Profit | $5.39M | $5.67M | $6.95M | $3.34M |
| Gross Profit Ratio | $0.47 | $0.50 | $0.53 | $0.58 |
| R&D Expenses | $13.19M | $12.78M | $5.49M | $5.008M |
| SG&A Expenses | $13.47M | $14.78M | $20.17M | $9.63M |
| Operating Expenses | $26.66M | $27.56M | $25.66M | $12.37M |
| Total Costs & Expenses | $32.62M | $33.17M | $31.80M | $14.81M |
| Interest Income | $0.00 | $3.08M | $1.89M | $831000.00 |
| Interest Expense | $0.00 | $0.00 | $32000.00 | $0.00 |
| Depreciation & Amortization | $685000.00 | $2.84M | $1.18M | $133000.00 |
| EBITDA | -$14.63M | -$26.61M | -$14.89M | -$8.55M |
| EBITDA Ratio | -$1.29 | -$2.36 | -$1.14 | -$1.48 |
| Operating Income | -$21.27M | -$21.90M | -$18.70M | -$8.68M |
| Operating Income Ratio | -$1.88 | -$1.94 | -$1.43 | -$1.50 |
| Other Income/Expenses (Net) | $6.38M | $7.62M | $2.60M | $483001.00 |
| Income Before Tax | -$14.89M | -$14.28M | -$16.11M | -$8.20M |
| Income Before Tax Ratio | -$1.31 | -$1.27 | -$1.23 | -$1.42 |
| Income Tax Expense | -$385000.00 | $0.00 | -$856000.00 | -$853610.00 |
| Net Income | -$14.50M | -$14.28M | -$15.25M | -$8.20M |
| Net Income Ratio | -$1.28 | -$1.27 | -$1.16 | -$1.42 |
| EPS | -$0.02 | -$0.02 | -$0.02 | -$0.01 |
| Diluted EPS | -$0.02 | -$0.02 | -$0.02 | -$0.01 |
| Weighted Avg Shares Outstanding | $805.72M | $818.79M | $810.72M | $807.35M |
| Weighted Avg Shares Outstanding (Diluted) | $805.72M | $818.72M | $810.72M | $807.30M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan